Clinical Trial Update: The Ameliorative Effects of GLP-1RA on Diabetic Cardiac Autonomatic Neuropathy [Phase 4]

View source ↗

Summary

A Phase 4 clinical trial update exploring the ameliorative effects of a GLP-1 receptor agonist on diabetic cardiac autonomic neuropathy; the study is currently …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Diabetic Autonomic Neuropathy
• Type 2 Diabetes Mellitus

Snippet

Sponsor: The First Affiliated Hospital with Nanjing Medical University | Conditions: Type 2 Diabetes, Diabetes With Diabetic Autonomic Neuropathy (Diagnosis) | Phase 4 | Status: RECRUITING